Multiple groups, 75% Caucasian, 17% Black, 3% Asian, 1% mixed race, 3% other.
特征
57 HIV-infected and 36 healthy volunteers, 50 mg dose of dolutegravir once daily, taken as a tablet either alone; (healthy volunteers) or coformulated with abacavir/lamivudine in the; Phase I studies and with emtricitabine/tenofovir in the Phase III study (HIVinfected participants).
生物地理组
Multiple groups, 75% Caucasian, 17% Black, 3% Asian, 1% mixed race, 3% other.